Detail akcie Baxter Intl online

Business Summary: Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. Its products are used in hospitals, rehabilitation centers, ambulatory surgery centers, and others.
Financial Summary: BRIEF: For the three months ended 31 March 2026, Baxter International Inc revenues increased 3% to $2.7B. Net loss before extraordinary items totaled $17M vs. income of $64M. Revenues reflect Pharmaceuticals segment increase of 7% to $621M, Medical Products and Therapies segment increase of 2% to $1.29B, Other segment increase of 15% to $90M, International segment increase of 12% to $1.27B.